ROCKVILLE, Md. -- The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has approved the sale and distribution of the Disintegrator PRO for clinical use. The Disintegrator PRO is a small electrical device that, with the push of a button, creates a controlled plasma arc that disintegrates an inserted hypodermic needle, leaving a harmless, blunted end.
"The healthcare industry generates hundreds of millions of used needles each year," says Joe Adkins, president of Safeguard Medical Devices, Inc. (d.b.a.: Disintegrator Products), manufacturers of The Disintegrator PRO. "FDA approval of The Disintegrator PRO paves the way for a safer workplace for our nations approximately 900,000 healthcare workers, while potentially saving the healthcare industry, and ultimately the American public, more than half a billion dollars annually."
The American Nursing Association has estimated that 1 million accidental needlesticks occur in the United States healthcare industry alone. In total, several billion used syringes end up in the solid waste system. Used needles can transmit numerous bloodborne pathogens, including HIV, hepatitis B and C, as well as other infections.
But, in less than three seconds, The Disintegrator PRO heats the used needle to 1,700 degrees centigrade (3,000 degrees Fahrenheit), effectively destroying the needle while eliminating any viruses or potentially harmful bacteria from the blunted end.
FDA approval of The Disintegrator PRO follows recent FDA approval of
The Disintegrator Plus, a similar device designed for home use by diabetic patients and others who utilize needles and lancets in the course of treating their medical conditions. Together, the Disintegrator units have received 28 patent claims in the U.S. and abroad, and represent a technological leap over traditional methods of disposing of used needles, such as storing in sharps containers or even coffee cans and pop bottles before placement in trash bins.
The Centers for Disease Control and Prevention estimates 62 to 88 percent of sharps injuries can potentially be prevented by use of safer medical devices.
The Disintegrator units are manufactured by Safeguard Medical Devices,
Inc. (d.b.a.: Disintegrator Products) of Cleveland, Ohio and distributed by Perfecta Products, Inc. of Berlin Center, Ohio.
Source: Safeguard Medical Devices, Inc.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.